Magenta Medical Funding: $100M Raised, Series D (2023)
Magenta Medical is based in New York. It has raised $100M in total funding. Latest round: Series D.
Magenta Medical funding overview
Magenta Medical is based in New York. Magenta Medical has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in May 2023. The round record for Magenta Medical runs through 2023; nothing later has been disclosed. Investors on record include OrbiMed Advisors, New Enterprise Associates (NEA), Pitango Venture Capital, ALIVE - Israel HealthTech Fund, Abiomed Inc., JAFCO Co., Ltd.. 6 distinct backers are named across the disclosed rounds.
Magenta Medical at a glance
Total raised
$100M
Latest round
Series D
Latest round date
May 2023
Headquarters
New York
Notable investors
OrbiMed Advisors, New Enterprise Associates (NEA), Pitango Venture Capital, ALIVE - Israel HealthTech Fund, Abiomed Inc., JAFCO Co., Ltd.
Frequently asked about Magenta Medical funding
How much has Magenta Medical raised?
Magenta Medical has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Magenta Medical?
OrbiMed Advisors, New Enterprise Associates (NEA), Pitango Venture Capital, ALIVE - Israel HealthTech Fund, Abiomed Inc., JAFCO Co., Ltd. are named among the investors backing Magenta Medical.
What was the latest Magenta Medical funding round?
The most recent disclosed round is a Series D, announced in May 2023.
Where is Magenta Medical based?
Magenta Medical is based in New York.
When did Magenta Medical last raise?
The last disclosed Magenta Medical round closed in May 2023 at Series D.
Every Magenta Medical figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.